Change in the usage of pump features predicts improvement of glycemic control

  • Insulin pumps offer a wide range of technical features designed to help patients with achieving optimal glycemic control. However, many patients do not achieve better glycemic control despite CSII therapy. In this study, we analyzed whether a change in using pump features was associated with an improvement in glycemic control. 197 patients with CSII treatment were analyzed at baseline and 12-weeks later (age 42.2 ± 14.3 yrs.; 59% female; diabetes duration 22.2 ± 11.9 yrs.; duration of CSII 9.4 ± 7.3 yrs.; baseline A1c 8.3 ± 0.9%). Change in using pump features (see table) were the independent variables of interest in a linear regression analysis on the difference in HbA1c (follow-up – baseline). The analysis was controlled for demographic (age, gender, BMI, education) and medical variables (diabetes duration, duration of CSII, use of CGM/FGM, complications, SMBG). Increased use of pump features standardized beta p Temporary basal rates -0.16 .027 Different basal rate profiles -0.09 .219 Bolus options 0.16 .031 BolusInsulin pumps offer a wide range of technical features designed to help patients with achieving optimal glycemic control. However, many patients do not achieve better glycemic control despite CSII therapy. In this study, we analyzed whether a change in using pump features was associated with an improvement in glycemic control. 197 patients with CSII treatment were analyzed at baseline and 12-weeks later (age 42.2 ± 14.3 yrs.; 59% female; diabetes duration 22.2 ± 11.9 yrs.; duration of CSII 9.4 ± 7.3 yrs.; baseline A1c 8.3 ± 0.9%). Change in using pump features (see table) were the independent variables of interest in a linear regression analysis on the difference in HbA1c (follow-up – baseline). The analysis was controlled for demographic (age, gender, BMI, education) and medical variables (diabetes duration, duration of CSII, use of CGM/FGM, complications, SMBG). Increased use of pump features standardized beta p Temporary basal rates -0.16 .027 Different basal rate profiles -0.09 .219 Bolus options 0.16 .031 Bolus calculators 0.02 .790 Analysis software -0.16 .025 CGM pairing -0.23 .002 An increased use of temporary basal rates as well as using analysis software more often predicted an improvement in HbA1c (see table). Linking a CGM system to the insulin pump was the strongest predictor of better glycemic control. In clinical practice, patients with CSII therapy should be educated how to make use of their pump features and should be encouraged to do so.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Institutes:Fakultät Humanwissenschaften / Lehrstuhl für Klinische Psychologie/Psychotherapie
Author:Dominic Ehrmann, Norbert Hermanns, Melanie Schipfer, Bernhard Lippmann-Grob, Thomas Haak, Bernhard Kulzer
Place of publication:Bamberg
Publisher:OPUS
Year of publication:2018
Pages / Size:1 pdf-Datei (1 S.)
Year of first publication:2017
Source/Other editions:Ursprünglich in: Diabetes : a journal of the American Diabetes Association 66 (2017) Suppl. 1, A274 (1040-P)
URL:https://opus4.kobv.de/opus4-bamberg/frontdoor/index/index/docId/52614
URN:urn:nbn:de:bvb:473-opus4-524137
DOI:https://doi.org/10.20378/irbo-52413
Document Type:Variety of texts
Language:English
Peer Review:Ja
Internationale Verbreitung:Ja
Open-Access-Zeitschrift:Nein
Publishing Institution:Otto-Friedrich-Universität Bamberg
Release Date:2018/08/02
Licence (German):License LogoDeutsches Urheberrecht